Change - Announcement of Appointment::Appointment of Independent Director

Issuer & Securities

Issuer/ Manager
Y VENTURES GROUP LTD.
Securities
Y VENTURES GROUP LTD. - SG1DH7000008 - 1F1
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
30-Jul-2021 18:08:19
Status
New
Announcement Sub Title
Appointment of Independent Director
Announcement Reference
SG210730OTHRPKT4
Submitted By (Co./ Ind. Name)
Lew Chern Yong
Designation
Executive Chairman and Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Tan Chade Phang as Independent Director of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's Sponsor, RHT Capital Pte. Ltd. (the "Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Leong Weng Tuck - Registered Professional, 6 Raffles Quay, #24-02, Singapore 048580, sponsor@rhtgoc.com

Additional Details

Date Of Appointment
01/08/2021
Name Of Person
Tan Chade Phang
Age
45
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
After reviewing the recommendation of the Nominating Committee, the Board of Directors (the "Board") of the Company approved Mr Tan Chade Phang's appointment as Independent Director of the Company with effect from 1 August 2021.

Mr Tan Chade Pang will also be appointed as Chairman of the Audit Committee and member of the Nominating and Remuneration Committees of the Company with effect from 16 August 2021. Please refer to the Company's announcement dated 30 July 2021 in relation to the change in composition of the Board and Board Committees of the Company for details.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
1. Independent Director (wef 1 August 2021)
2. AC Chairman (wef 16 August 2021)
3. NC Member (wef 16 August 2021)
4. RC Member (wef 16 August 2021)
Professional qualifications
Nil
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
January 2009 to Present: Voyage Research Pte Ltd - Chief Executive Officer
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Directorship:

1. Bodhi Tree Network Pte. Ltd.
2. Dapai International Holdings Co., Ltd*
3. TBK & Sons Holdings Ltd
4. TIH Limited
5. Transcorp Holdings Limited

*Delisted from the Official List of the SGX-ST on 17 July 2018.
Present
Directorship:

1. Camsing Healthcare Limited
2. Revez Corporation Ltd.
3. Luminor Financial Holdings Limited (formerly known as Starland Holdings Limited)
4. OUE Lippo Healthcare Limited
5. Small and Middle Capitalisation Companies Association
6. Voyage Research Pte. Ltd.

Principal commitment: Voyage Research Pte Ltd - Chief Executive Officer
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
Yes
If Yes, Please provide full details
Mr Tan was appointed as Independent Director of Dapai International Holdings Co., Ltd. ("Dapai") in March 2016 and was subsequently appointed as Audit Committee Chairman of Dapai to oversee the agreed-upon procedures (conducted by BDO LLP) and special audit (conducted by KordaMentha Pte Ltd) in consultation with the Exchange on matters relating to Dapai prior to his appointment as an Independent Director of Dapai. The findings of the special audit report was released on SGXNET on 7 July 2017.
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
1. Camsing Healthcare Limited
2. Dapai International Holdings Co., Ltd
3. Luminor Financial Holdings Limited (formerly known as Starland Holdings Limited)
4. OUE Lippo Healthcare Limited
5. Revez Corporation Ltd.
6. TBK & Sons Holdings Ltd
7. TIH Limited
8. Transcorp Holdings Limited
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable.